The Promise and Challenges of CAR-T Gene Therapy
- PMID: 29167891
- DOI: 10.1001/jama.2017.15605
The Promise and Challenges of CAR-T Gene Therapy
Similar articles
-
CAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies?Immunotherapy. 2015;7(5):545-61. doi: 10.2217/imt.15.6. Immunotherapy. 2015. PMID: 26065479 Free PMC article. Review.
-
Late Events After CD-19 CAR-T Treatment.Biol Blood Marrow Transplant. 2020 Jan;26(1):e1-e2. doi: 10.1016/j.bbmt.2019.10.020. Epub 2019 Oct 25. Biol Blood Marrow Transplant. 2020. PMID: 31669398 Review. No abstract available.
-
CAR T-cell therapy in refractory large B-cell lymphoma.Lancet Oncol. 2018 Jan;19(1):e19. doi: 10.1016/S1470-2045(17)30928-2. Epub 2017 Dec 14. Lancet Oncol. 2018. PMID: 29249304 No abstract available.
-
An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells.Sci China Life Sci. 2016 Apr;59(4):379-85. doi: 10.1007/s11427-016-5035-4. Epub 2016 Mar 24. Sci China Life Sci. 2016. PMID: 27009300
-
Relapses After CAR-T Therapy.JAMA. 2018 Nov 13;320(18):1850. doi: 10.1001/jama.2018.17585. JAMA. 2018. PMID: 30422179 No abstract available.
Cited by
-
Cell Surface Engineering Tools for Programming Living Assemblies.Adv Sci (Weinh). 2023 Dec;10(34):e2304040. doi: 10.1002/advs.202304040. Epub 2023 Oct 12. Adv Sci (Weinh). 2023. PMID: 37823678 Free PMC article. Review.
-
How Can the Microbiome Induce Carcinogenesis and Modulate Drug Resistance in Cancer Therapy?Int J Mol Sci. 2023 Jul 24;24(14):11855. doi: 10.3390/ijms241411855. Int J Mol Sci. 2023. PMID: 37511612 Free PMC article. Review.
-
Metabolic Glycoengineering: A Promising Strategy to Remodel Microenvironments for Regenerative Therapy.Stem Cells Int. 2023 Feb 13;2023:1655750. doi: 10.1155/2023/1655750. eCollection 2023. Stem Cells Int. 2023. PMID: 36814525 Free PMC article. Review.
-
Resource utilization in patients with large B-cell lymphoma receiving tisagenlecleucel and axicabtagene ciloleucel.Bone Marrow Transplant. 2023 May;58(5):590-593. doi: 10.1038/s41409-023-01934-4. Epub 2023 Feb 11. Bone Marrow Transplant. 2023. PMID: 36774431 No abstract available.
-
Advanced nanomaterial for prostate cancer theranostics.Front Bioeng Biotechnol. 2022 Nov 1;10:1046234. doi: 10.3389/fbioe.2022.1046234. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36394009 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
